Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision
Status:
Terminated
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of ranibizumab for the treatment of
macular edema (ME) secondary to branch retinal vein occlusion (BRVO) in patients with initial
fair visual acuity.